Drug intelligence / Profile preview

COLDSORE-FX

Development stage
Unknown
Lead developer
Lisoma Canada
Modality
Small Molecules
Administration
Topical
01

Overview

**COLDSORE-FX** is a 2g topical ointment natural health product (NPN 80021252) for treating cold sores (herpes labialis), clinically proven to shorten healing time by an average of 4 days and relieve associated pain.[1][2][6][8] Its key active ingredient is **Propolis ACF** (Antiviral Complex of Flavonoids), a standardized 3% extract (30mg/g, dried herbal equivalent 100mg, 3.3:1 ratio) derived from Canadian propolis collected by honeybees (Apis mellifera) from plant resins.[2][4][6][8] It works via direct virucidal activity against herpes simplex virus, inhibition of viral replication in infected cells, anti-inflammatory and anesthetic effects for pain relief, and stimulation of connective tissue regeneration to accelerate healing; it can be applied at any stage of the cold sore cycle.[8] Non-medicinal ingredients include white petrolatum, heavy mineral oil, lanolin, and ethanol; apply topically 4-6 times daily for adults.[2][8] From the makers of COLD-FX, distributed under license from Lisoma Canada Ltd. by Valeant Canada LP.[6][8]

Brand names
COLDSORE-FXCOLD SORE-FXCold Sore F/X
02

Targets

HSV-1 (Herpes simplex virus type 1)

Beyond the preview

Go deeper on COLDSORE-FX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COLDSORE-FX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call